Pk. Banerjee et Oc. Snead, THALAMIC NMDA RECEPTORS IN THE GAMMA-HYDROXYBUTYRATE MODEL OF ABSENCESEIZURES - A CEREBRAL MICROINJECTION STUDY IN RATS, Neuropharmacology, 34(1), 1995, pp. 43-53
The possible role of thalamic NMDA receptors in the generation of expe
rimental absence-like seizures was studied in rats. Bilaterally synchr
onous spike wave discharges were induced by gamma-hydroxybutyric acid
(GHB) and were recorded simultaneously from different thalamic nuclei
and the layers I-IV of frontoparietal cortex. Bilateral infusions of N
MDA into thalamic mediodorsal nucleus, the intralaminar central latera
l/paracentral nucleus, ventroposterolateral, or reticular nucleus of t
he thalamus in conscious rats, prior to GHB administration suppressed
GHB-induced SWD in a dose dependent manner. However, no such suppressi
on of GHB-induced SWD was observed when NMDA infusions were made into
the above thalamic sites after the onset or development of GHB-induced
SWD. Pretreatment with high doses of competitive (CGP 43487) or non-c
ompetitive NMDA receptor antagonists (MK-801 and ketamine) also dose d
ependently suppressed GHB-induced SWD. Both MK-801 and CGP 43487 dose
dependently antagonized NMDA-mediated inhibition of GHB-induced SWD ac
tivity but at lower doses did not produce significant inhibition of GH
B-induced SWD. The anti-SWD effects of NMDA, MK-801 and ketamine but n
ot CGP 43487 were more pronounced in the mediodorsal and intralaminar
thalamic nuclei than in the ventroposterolateral or reticular nucleus
of thalamus. Because low doses of NMDA antagonists failed to disrupt t
he generation of seizures in the GHB model, these findings do not supp
ort a role for thalamic NMDA receptors in the pathogenesis of absence-
like seizures induced by gamma-hydroxybutyric acid.